Celiac Disease: A Review from Genetic to Treatment
- PMID: 38444380
- PMCID: PMC10994635
- DOI: 10.61186/ibj.4028
Celiac Disease: A Review from Genetic to Treatment
Abstract
Celiac disease (CD) is a complex disorder influenced by genetic and environmental factors. When people with a genetic predisposition to CD consume gluten, an inflammatory response is triggered in the small intestine, and this reaction can be alleviated by the elimination of gluten from the diet. The clinical manifestations of CD vary greatly from person to person and begin at a young age or in adulthood. Influence of genetic factors on CD development is evident in carriers of the DQ2 and/or DQ8 allele. HLA genotypes are associated with gut colonization by bacteria, particularly in individuals suffering from CD. In addition, beneficial gut microbes are crucial for the production of DPP-4, which plays a key role in immune function, as well as metabolic and intestinal health. Therefore, probiotics have been recommended as a complementary food supplement in CD.
Keywords: Celiac disease; Dipeptidyl peptidase 4; HLA-DQ antigens; Probiotics.
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Jedwab CF, Roston BCdMB, Toge ABFdS, Echeverria IF, Tavares GOG, Alvares MA, et al. O papel dos probióticos na resposta imunológica e na microbiota fecal de crianças com doença celíaca: uma revisão sistemática. Rev Paul Pediatr. 2022;40:e2020447.
-
- Tonutti E, Bizzaro N. Diagnosis and classification of celiac disease and gluten sensitivity. Autoimmun Rev. 2014;13(4-5):472–6. - PubMed
-
- Björck S, Lynch K, Brundin C, Agardh D. Repeated screening can be restricted to at-genetic-risk birth cohorts. J Pediatr Gastroenterol Nutr. 2016;62(2):271–5. - PubMed
-
- Green PH, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol. 2015;135(5):1099–106. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous